Publikationen in Zusammenarbeit mit Forschern von Centro Nacional de Microbiología (15)

2018

  1. Erratum to “Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe – Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18” [Vaccine 35 (2017) 4828–4835] (S0264410X17309659) (10.1016/j.vaccine.2017.07.057))

    Vaccine

  2. Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 european countries, 2010 to 2016

    Eurosurveillance, Vol. 23, Núm. 5

2017

  1. Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18

    Vaccine, Vol. 35, Núm. 37, pp. 4828-4835

2013

  1. Interleukin 28B rs12979860 (CT/TT) genotype is associated with milder hepatic damage in the natural evolution of HCV/HIV coinfection

    Journal of Interferon and Cytokine Research, Vol. 33, Núm. 1, pp. 43-47

2012

  1. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis

    Cytokine, Vol. 57, Núm. 3, pp. 332-336

2011

  1. Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza

    BMC Infectious Diseases, Vol. 11

2010

  1. Assessing the burden of paediatric influenza in Europe: The European paediatric influenza analysis (EPIA) project

    European Journal of Pediatrics, Vol. 169, Núm. 8, pp. 997-1008

  2. Host adaptive immunity deficiency in severe pandemic influenza

    Critical Care, Vol. 14, Núm. 5

  3. Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin

    European Cytokine Network, Vol. 21, Núm. 2, pp. 84-91

2009

  1. Diagnóstico microbiológico de las infecciones virales respiratorias

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 27, Núm. 3, pp. 168-177

2007

  1. Neuraminidase antibodies and H5N1: Geographic-dependent influenza epidemiology could determine cross-protection against emerging strains [3]

    PLoS Medicine

2005

  1. RNA extraction prior to HIV-1 resistance detection using Line Probe Assay (LiPA): Comparison of three methods

    Journal of Clinical Virology, Vol. 32, Núm. 4, pp. 265-271

  2. Resistencias genotípicas en pacientes con infección por el virus de la inmunodeficiencia humana. Correlación con las pautas terapéuticas empleadas en su tratamiento

    Medicina Clinica, Vol. 124, Núm. 16, pp. 601-605

2004

  1. Prevalence of genotypic resistance in untreated HIV-infected patients

    Revista Espanola de Quimioterapia, Vol. 17, Núm. 3, pp. 250-256

2001

  1. Rapid and sensitive diagnosis of human adenovirus infections by a generic polymerase chain reaction

    Journal of Virological Methods, Vol. 92, Núm. 2, pp. 113-120